Taiwan FDA registration b35d99e84518cef5611497fd14694b2e
Longteng K in vitro reagent group
TW: 龍騰K他命體外試劑組
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. new market factory·Registered Feb 18, 2020 – Feb 18, 2030ActiveRegistration details
- Analysis ID
- b35d99e84518cef5611497fd14694b2e
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Longteng Biotechnology Co., Ltd. new market factory
Product details
- Intended Use
- Qualitative detection of Khimmine and its metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.0001 苯環利定試驗系統
- Import Information
- Domestic
Dates and status
- Registration Date
- Feb 18, 2020
- Expiry Date
- Feb 18, 2030
About this record
Access comprehensive regulatory information for Longteng K in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b35d99e84518cef5611497fd14694b2e and manufactured by Longteng Biotechnology Co., Ltd. new market factory. The authorized representative in Taiwan is Longteng Biotechnology Co., Ltd. new market factory.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices